nci scientific program
DESCRIPTION
NCI Scientific ProgramTRANSCRIPT
PR
OG
RA
M AT A
GLA
NC
E
Wednesday, 3rd April, 2013
Thursday, 4th April, 2013
(Hall A) (Hall B)
09:00-09:15 Introduction 09:00-11:00 Workshop I: Nursing 09:15-09:45 Memorial Lecture:
Prof. Lotfy Abo Elnasr - Prof. El-Sebaie 09:45-10:45 Session I: Updates in The Diagnosis of Breast Cancer
10:45-11:00 Coffee Break 11:00-11:30 Coffee Break
11:00-12:00 Session II: Controversies in The Surgical Management of Breast Cancer
11:30-13:30 Workshop II: Molecular Diagnostics in Breast Cancer 12:00-12:40 Debate: Chemoprevention of Breast Cancer12:40-14:00 Session III: Controversies in Adjuvant Breast
Cancer Therapy
14:00-15:30 Lunch Break 13:30-15:00 Lunch Break
15:30-17:00 NOVARTIS SYMPOSIUM GIST AND NET 15:00-17:30 Workshop II: Molecular Diagnostics in Colorectal Cancer17:00-18:30 (Hall C) Session IV: Hepatobiliary Cancer: Diagnostics and Interventional Radiology Standards of 2013
18:30-20:00 (Hall A) Opening Ceremony20:00-22:00 Dinner Symposium (GSK)
(Hall A) (Hall B)
09:00-10:30 Session V: Approaches in Management of Early 09:00-10:30 Workshop III: Breast Cancer and PregnancyStage Colorectal Carcinoma
10:30-11:30 Presidential Lecture CML
11:30-12:00 Coffee Break 11:30-12:00 Coffee Break
PR
OG
RA
M AT A
GLA
NC
E12:00-12:30 Memorial Lecture: Prof. Hassan Awad 12:00-14:00 Janssen Cilag Workshop IV: Pain 12:30-14:15 Session VI: Different Approaches for
Locallyadvanced and Metastatic CRC14:15-15:00 Session VII: Neoadjuvant Treatment for Rectal
Carcinoma: 2013
15:00-16:30 ROCHE SYMPOSIUM - Lunch Break
16:30-17:50 Session VIII: Advanced Breast Cancer 16:30-17:30 Session XIII: Novel Approaches in Current Current Updates Management
17:50-18:30 LEO PHARMA: Special Lecture VTEin Breast Cancer 17:30-18:00 PFIZER: Special Lecture18:30-19:30 NOVARTIS SYMPOSIUM Breast Cancer
20:30 Gala Dinner (Only by Invitation)
(Hall A) (Hall B)
09:00-10:10 Session IX: Upper GI Tumors: Controversies in 10:00-12:00 Workshop V: the Current Management Elsevier: The Art of Scientific Publication
10:00-10:30 Coffee Break
10:30-11:45 Session X: Updates in Diagnosis & Interventional Management of GIT Cancers
12:00-13:00 Friday prayer
13:00-14:00 Lunch
14:00-15:00 Session XI: Pancreatic Cancer: Avenues to 14:00-15:30 Session IVX: Poster Discussionthe New Standards
15:00-16:50 Session XII: Advances in the Management of Hepatocellular Carcinoma
17:00-17:30 Memorial Lecture: Prof. Nazligad El Mawla 15:30-17:30 Session VX: Advances in Radiodiagnosis
17:30-18:30 Closing Remarks and Recommendation
Friday, 5th April, 2013
PROGRAM
Wednesday, 3rd April, 2013
08:30-09:00 Registration
Hall (A)
09:00-09:15 Introduction
09:15-09:45 Memorial Lecture: Prof. Lotfy Abo Elnasr - Prof. El-sebaie Chairpersons: Amal Samy - Dimitris Bafaloukos - Kamal El Ghamrawy - Sherif Omar - Zekri Khaled
09:15-09:45 Breast Cancer in Egypt: Past, Present and FutureHussein Khaled (Egypt)
09:45-10:45 Session I: Updates in the Diagnosis of Breast CancerChairpersons: Dorria Salem - Magda Mourad - Mohamed Shaalan - Moharam El Badawi -
Sami El Khatib - Walid Omar
09:45-10:05 Role of Contrast Mammography in Screening and DiagnosisMaha Helal (Egypt)
10:05-10:25 Controversial Role of PET CT in Breast CancerHussein Abdel Dayem (USA)
10:25-10:45 Molecular characterizations of Breast cancer Saad Eissa (Egypt)
10:45-11:00 Coffee Break
11:00-12:00 Session II: Controversies in the Surgical Management of Breast Cancer Chairpersons: Ahmed El-Saeed - Faisal Amer - Hassan Meebed - Moustafa Abo El Nasr -
Osama Soliman
11:00-11:20 "HER2gene status": new evaluation criteria Millo Fratini (Switzerland)
11:20-11:40 Challenges in breast Conservative Surgery: The Surgeon's PerspectiveAhmed Farahat (Egypt)
11:40-12:00 Updates in The Management of Axillary Lymph nodes in Breast Cancer.Omar Zakria (Egypt)
12:00-12:40 Debate: Chemoprevention of Breast CancerChairpersons: Gamal El-Houseny - Nasr Al-Lahloubi - Tanja Cufer - Yasser Abdel Kader
12:00-12:40 Debates in Breast Cancer ChemopreventionYes: Rabab Gaafar(Egypt)No: Alaa Kandil(Egypt)
PROGRAM
Wednesday, 3rd April, 2013 Hall (A)
12:40-14:00 Session III: Controversies in Adjuvant Breast Cancer Therapy
Chairpersons: Hamdy Abdel Azim - Heba El-Zawahry - Magda El Mongy - Manal Moawad - Mohsen Barsoum
12:40-13:00 Updates on chemotherapy and Targeted therapy in Adjuvant BreastTanja Cufer (Slovenia)
13:00-13:20 Should partial breast radiotherapy be a standard of care?John Yarnold (UK)
13:20-13:40 Hypofractionation for early breast cancerJohn Yarnold (UK)
13:40-14:00 Controversial Issues in adjuvant Hormonal therapy of Breast CancerSanna El Sukhun (Jordan)
14:00-15:30 Lunch Break
15:30-17:00 NOVARTIS Symposium GIST and NET
Chairpersons: Eman Fouad - Hamdy Abdel Azim - Mostafa Manieh
15:30-15:50 NET PathologyNadia Mokhtar (Egypt)
15:50-16:10 NET TreatmentYasser Abdel Kader (Egypt)
16:10-16:30 GISTAxel Le Cene. Gustave Roussy (France)
16:30-16:50 Metastatic GISTMostafa El-Serafi (Egypt)
16:50-17:00 Discussion
18:30-20:00 Opening Ceremony
20:00-21:00 Symposium (GSK): Managing Her2 Positive Metastatic Breast Cancer, Doing a Better Job?
Chairpersons: Abbas Omar- Rabab Gaafar - Yaser Abdel Kader
20:00-20:30 Lapatinib as first line treatment in Her2 positive MBCHeba El-zawahry (Egypt)
20:30-21:00 CNS metastasic in Her2 positve breast cancer, the systemic side of the story.Hamdy A Azim (Egypt)
21:00-22:00 GSK Dinner
PROGRAM
Wednesday, 3rd April, 2013
Hall (B)
09:00-11:00 Workshop I: Nursing Workshop1- Rehabilitation of breast cancer patients2- Maintaining quality of life for breast cancer patients3- Psychological care support for breast cancer patients4- Rehabilitation of colorectal cancer patients5- Psychological support for colorectal Cancer patients
11:00-11:30 Coffee Break
11:30-17:30 Workshop II: Molecular Diagnostics for Clinical Oncology
Organized by: National Cancer Institute - Egypt and Mediterranean Multidisciplinary Oncology Forum (MMOF)
Session I: Breast Cancer Chairpersons: Dimitris Bafaloukos, Keith Miller, Nadia Mokhtar
11:30-12:00 Implications of breast cancer stem cells: a base for a molecular classificationNadia Mokhtar (Egypt)
12:00-12:30 Clinical implementation and utility of molecularly defined Breast Cancer subsetsHelena Linardou (Greece)
12:30-13:00 25 years of external quality assessment (EQA): Where are the pitfalls?Keith Miller (UK)
13:00-13:30 Panel Discussion: Critical issues in implementation of Diagnostic Accuracy: Pathology to molecular medicine
13:30-15:00 Lunch Break
Session II: Colorectal CancerChairpersons: Magda Mourad, Milo Frattini, Samuel Murray
15:00-15:30 K-ras mutations in metastatic colorectal cancerMilo Frattini (Switzerland)
15:30-16:00 Her-2 in breast and colorectal cancers: the same marker but different evaluation criteria and different clinical implications.Milo Frattini (Switzerland)
16:00-16:30 Examining the correlation between inherited and somatic carcinogenesis in Colorectal cancer: How to manage integration.Samuel Murray (UK)
16:30-17:00 Challenges of providing a high quality diagnostic service to the community and quality control issues.Keith Miller (UK)
17:00-17:30 Panel Discussion: Critical issues in implementation of diagnostic accuracy: Pathology to molecular medicine.
PROGRAM
Wednesday, 3rd April, 2013
Hall (C)
17:00-18:30 Session IV: Hepatobiliary Cancer: Diagnostics and Interventional Radiology Standards of 2013
Chairpersons: Ahmed El-Dory - Ashraf Omar - Ekram Hamed - Inas Abdel Halim - Osama El Malt
17:00-17:30 Hepatocellular carcinoma: Can MR imaging replace tissue diagnosis?Sherif Nour (USA)
17:30-18:00 Updates on liver embolization DEB TACE and Y-90 Radio-embolizationKevin Kim (USA)
18:00-18:30 Interventional MRI: Expanding the options for patients with GIT malignanciesSherif Nour (USA)
PROGRAM
Thursday, 4th April, 2013
(Hall A)
09:00-10:30 Session V: Approaches in Management of Early Stage Colorectal Carcinoma
Chairpersons: A. Aziz Belal - Ahmed Seleem - Inas El-Attar - Mounier Abo El-Ela - Sabry Shaarawy
09:00-09:20 NCI hospital based cancer registry 2002-2010Nelly Ali Eldin (Egypt)
09:20-09:40 Laparoscopic colorectal surgery, how far it can be safe?Waheed Yosry (Egypt)
09:40-10:10 Total peritoneal reconstruction after abdomeno-peroneal resectionOmaya Abdel Hamid (Egypt)
10:10-10:30 Update on adjuvant therapy of colon cancer; what works, what does not and what is next? Nasr Al-Lahloubi (Egypt)
10:20-10-30 Discussion
10:30-11:30 Presidential Lecture CML
Chairpersons: Alaa El-Haddad - Azza Kamal - Hamdy El Zawam - Hossam Kamel - Mervat Mattar - Mohamed Abdel Mooti
10:30-11:00 Choice of therapy in today's newly diagnosed CML patientsHossam Kamel (Egypt)
11:00-11:30 Like Sailing Down the Nile…The History of Therapy for Chronic Myeloid LeukaemiaMicheal Copeman (Australia)
11:30-12:00 Coffee Break
12:00-12:30 Memorial Lecture: Prof. Hassan Awad
Chairpersons: Ehsan El Ghoneimy - Hany Akosh - Laila Moussa - Mervat El Naggar - Samy El Badawy - Somia Ezzat
12:00-12:30 The role of pre-operative radiation in rectal carcinoma- an overviewMay Abdel Wahab (USA)
PROGRAM
Thursday, 4th April, 2013
(Hall A)
12:30-14:15 Session VI: Different Approaches for Locally Advanced and Metastatic CRC
Chairpersons: Abbas Omar - Hany El Naggar - Magda Mostafa - Mohamed Abbas - Naeir El-Ghamry
12:30-12:50 Treatment of local recurrence after rectal resection including sacrectomyMedhat Khafaga (Egypt)
12:50-13:10 Interventional treatment of refractory ascitisLouis G Martin (USA)
13:10-13:30 Systemic Chemotherapy for metastatic CRC: a molecular approachMostafa El Serafi (Egypt)
13:30-13:50 Colonic stenting for advanced CRC Amr El Saadani (KSA)
13:50-14:15 Discussion
14:15-15:00 Session VII: Neoadjuvant Treatment for Rectal Carcinoma: 2013
Chairpersons: Hanna Kohail - Magdi Saber - Mostafa El Serafi - Omar Zaky - Saeed El Newiem - Tarek Hashem
14:15-15:00 Current Status of ManagementMohsen Mokhtar (Egypt)
Interviewer: Ola Khorshid (Egypt)
15:00-16:30: ROCHE Symposium and Lunch BreakOrchestrating The Treatment of Breast Cancer
Chairpersons: Nasr Al Lahlouby - Nivene Gado - Saeed El Noeam
15:00-15:30 Management of HER2 positive eBC; Recent UpdatesAlaa Kandil (Egypt)
15:30-16:00 First Line Treatment of HER2 positive mBC; What is best for the patients?Ibtessam Saad Eldeen (Egypt)
16:00-16:30 Chemotherapy options in MBC; Thinking SmartOla Khorshid (Egypt)
PROGRAM
Thursday, 4th April, 2013
(Hall A)
16:30-17:50 Session VIII: Advanced Breast Cancer Current Updates
Chairpersons: Abbas Omar - Eman Fouad - Hazim El Akkad - Samuel Murray - Shawki El HaddadTanja Cufer
16:30-16:50 Optimal systemic treatment for locally advanced breast cancerAhmed Saad El Din (KSA)
16:50-17:10 Triple negative breast cancer: biology and new therapeutic approachesAhmad Awada (Belgium)
17:10-17:30 Advances in the treatment of HER 2 positive metastatic breast canerHelena Linardou (Greece)
17:30-17:50 Brain metastasis in breast cancerNuhad Ibrahim (USA)
17:50-18:30 LEO Pharma Special Lecture VTE in Breast Cancer
Chairpersons: Magdy El Shahawy - Nasr Al-Lahlouby - Salah El Mesedy - Wafaa El-Metnawey -Wafaa Tahaa
17:50-18:30 Update on cancer related thrombosisAnthony Maraveyas (UK)
18:30-19:30 NOVARTIS Symposium: Breast Cancer
Chairpersons: Heba El-Zawahry - Ismail Siala - Yousry Gouda
18:30-19:30 How does resistance to endocrine therapy affect the Breast Cancer outcome?Tanja Cufer (Slovenia)
Role of m-TOR in Metastatic Breast cancerAre m-TOR Inhibitors effective in bone and Visceral MetastasisRabab Gaafar (Egypt)
20:30 Gala Dinner (Only by Invitation)
PROGRAM
Thursday, 4th April, 2013
(Hall B)
09:00-10:30 Workshop III: Breast Cancer and Pregnancy
Chairpersons: Helena Linardou - Hesham El Ghazaly - Hoda Abdel Baki - Lobna Ezz El Arab - Rabab Gaafar
09:00-09:20 Consideration in the local management of breast cancer during pregnancyOmar Z. Youssef (Egypt)
09:20-09:45 Systemic treatment of breast cancer during pregnancySanaa El Sukhun (Jordan)
09:45-10:10 Fertility considerations and subsequent pregnancy in young breast cancer patientsHatem Abdel Azim (Belgium)
10:10-10:30 Case discussions - 2 casesSanaa El Sukhun (Jordan)
12:00-14:00 JANSSEN CILAG Workshop IV: Pain Moderators: Ahmed Helmy - Khaled Abdel Hameed
Opioids in cancer patients (basic concepts and clinical uses) Interactive cases presentation.
15:00-16:30 Lunch
16:30-17:30 Session XIII: Novel Approaches in Current ManagementChairpersons: Ahmed El Zawawy - Hassan Abdalla - Nabil El Bolkeiny - Nayera Anwar -
Sameh Shamaa - Samia Akel
16:30-16:40 Diagnostic approach of Micro RNA in diagnosis of hepatocellular carcinomaAbdel Hady Ali (Egypt)
16:40-16:50 Dose escalation in rectal cancer- dosimetric analysis"Ehab Khalil (KSA)
16:50-17:00 Role of pulmonary metastatectomy in breast and GIT tumorsAbdel Rahman M. Abdel Rahman (Egypt)
17:00-17:10 Tumor Marker in Breast CancerAmal Fawzy (Egypt)
17:10-17:20 Role of immunostaining and image-guided FNA cytology in the diagnosis of HCCMohamed Zaakouk (Egypt)
17:20-17:30 Discussion
17:30-18:00 PFIZER: Special Lecture Sustained Benefit of aromatase Inhibitors in adjuvant Therapy for Postmenopausal Breast Cancer Patients - Heba El Zawahry (Egypt)
PROGRAM
Friday, 5th April, 2013
(Hall A)
09:00-10:10 Session IX: Upper GI Tumors: Controversies in the Current Management
Chairpersons: Ashraf Barakat - Assem Roustom - Mohamed Saad Zaghloul - Mostafa Maniea -Samir Shehata
09:00-09:20 Role of endosonography in the management of upper GI tumorsRathod (India)
09:20-09:40 Advances in surgical management of gastric carcinoma Mohamed Gamil (Egypt)
09:40-9:55 Optimal management for locally advanced gastric and esophageal tumors:Radiotherapy perspectivesTarek Shouman (Egypt)
9:55-10:10 Role of targeted therapy in Stomach CancerOsman Mansour (Egypt)
10:10-10.30 Coffee Break
(10:30-11:45) Session X: Updates in Diagnosis & Interventional Management of GIT Cancers
Chairpersons: Amr Abdel Aziz - Assma Abo Rabia - Atef Yousef - Fouad AbouTaleb - Mohamed El-Safa
10:30-10:50 Role of PET in GIT tumorsHussein Abdel Dayem (USA)
10:50-11:10 Portal vein embolization before hepatic resectionWael E. Saad (USA)
11:10-11:30 Pancreatic cancer: Overview of imaging, diagnosis and percutaneous interventionSherif Nour (USA)
11:30-11:45 Discussion
12:00-13:00 Friday prayer
13:00-14:00 Lunch
PROGRAM
Friday, 5th April, 2013
(Hall A)
(14:00-15:00) Session XI: Pancreatic Cancer: Avenues to the New Standards
Chairpersons: Ahmed Badeeb - Ahmed Morsy - Nadia El Deeb - Sherif Abd El Aziz - Sherif MamounSalah Abdel Moneim
14:00-14:20 Advances in Pancreatic SurgeryHussein Soliman (Egypt)
14:20-14:40 Current status of Adjuvant Systemic Treatment in Pancreatic CarcinomaAhmed Abdel Maboud (Egypt)
14:40-15:00 Updates in the Management of Metastatic Pancreatic CarcinomaEmad Hamada (Egypt)
(15:00-16:50) Session XII: Advances in the Management of Hepatocellular Carcinoma
Chairpersons: Ibtesam Saad El Din - Mohamed Lotayef - Neveen El Hefnawy - Osama El Malt - Thoria Abdel Hamid - Yosry Rustum
15:00-15:20 Novel markers in HCCIman Attia (Egypt)
15:20-15:40 How to avoid complications in major hepatectomies?Mohamed El Kalawy (Egypt)
15:40-16:00 Anaethetic techniques and hepatobiliary cancer recurrenceKhaled Abdel Hamid (Egypt)
16:00-16:20 Novel treatment in advanced hepatocellular carcinomaMagdy Saber (Egypt)
16:20-16:40 Sterotactic body radiosurgery in the management of Hepatocellular carcinomaMay Abdel Wahab (USA)
16:40-16:50 Discussion
(17:00-17:30) Memorial Lecture: Professor Nazli Gad El Mawla
Chairpersons: Ahmed El Khodary - Heba El-Zawahry - Hussien Khaled - Magdi Saber - Nasr Al-Lahlouby - Rabab Gaafar
17:00-17:30 The long term benefits of neoadjuvant in breast cancer with a special emphasis in TNBC.Ahmad Awada (Belgium)
17:30-18:30 Closing Remarks and Recommendation
PROGRAM
Friday, 5th April, 2013
(Hall B)
(10:00-12:00) Workshop V: Elsevier: The Art of Scientific Publication
Chairpersons: Ahmed Abdel Maboud - Heba Shaker - Hanan Ramadan
10:00-10:45 Authoring a world class paper Anne Marie Pordon (Jordan)10:45-11:00 Discussion
11:00-11:45 The impact Factor and other bibliometricsAnne Marie Pordon (Jordan)
11:45-12:00 Discussion
12:00-13:00 Friday prayer
13:00-14:00 Lunch
(14:00-15:30) Session IVX: Poster Discussion
Chairpersons: Amani Helal - Hatem Abou Elkassem - Ibrahim Abdel Salam - Iman Gouda - Khaled Abou El Einein - Manar Mounir
P1. A prospective pharmacokinetic study of docetaxel in breast cancer patients in relation to CYP3A4 Activity
P2. A study of serum levels of vitamin D, ionized calcium and phosphorus in Egyptian breast cancer females: a Case Control Study
P3. Pancreatic Carcinoma Role of Multislice tripahsic CT in assessment of tumor resectability, prospective study
P4. Dose escalation in rectal cancer; for whom, why and how?P5. Molecular Characterization of Local Streptomyces Isolates and Determination of their
Antimicrobial and Anticancer ActivitiesP6. Fertility considerations and subsequent pregnancy in young breast cancer patientsP7. Natural history of untreated hepatocellular carcinoma: A single institute
retrospective studyP8. Breast cancer laterality among Egyptian patients and its correlation with treatments
and survivalP9. Role of hypermethylation of RASSF1A & PROTOCADHERIN-10 promoter regions as
molecular diagnostic and prognostic markers in Egyptian breast cancer patients P10. Peripheral blood mammaglobin gene expression for diagnosis and prediction of
metastasis in breast cancer patients
PROGRAM
Friday, 5th April, 2013
(Hall B)
P11. Breast cancer laterality among Egyptian patients and its correlation with treatments and survival
P12. Natural history of untreated hepatocellular carcinoma in Egypt: a retrospective cohort study
P13. Research in medical oncology: Past achievement and future priorities.P14. Evaluation of The Etiological Spectrum of Malignant Obstructive Jaundice At National
Cancer Institute, Cairo University
(15:30-17:30) Session XV: Advances in Radiodiagnosis
Chairpersons: Ahmed Sami - Ekram Hamed - Hossam Shalabi - Moharram El Badawy - Sherif Hegab
15:30-16:00 Interventional management of cholangio carcinomaWael Saad (Egypt)
16:00-16:30 Colorectal cancer: The radiologist' inputSherif Nour (USA)
16:30-17:00 Interventional management of benign and malignant biliary obstructionLouis Martin (USA)
17:00-17:30 Discussion
On behalf of everyone at NCI Conference, we would like to thank you all for your very generous sponsorship of our event, NCI Conference 2013 .It has been a great pleasure working with you.
This event would not have been a success without the generous support you have provided us throughout. We deeply appreciate the willingness with which you have and continue to sponsor our efforts to make our town a healthier, happier place to live in.
We sincerely hope that this association will be maintained and that you will continue to support us in our future endeavors.
Thank You
Platinum Sponsors